mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
0.9 |